S R C Benson1, J Blue, K Judd, J E Harman. 1. St. Marks Women's Health, 10 St. Marks Rd., Remuera, P.O. Box 99455, Auckland, New Zealand. w.benson@smwh.co.nz
Abstract
OBJECTIVE: This study investigated the use of ultrasound (US) as a first-line diagnostic tool. METHODS: All women attending our breast center underwent bilateral whole-breast US in addition to all other investigations, and results were documented prospectively and preoperatively. RESULTS: Of 796 patients with breast cancer, US was positive in 710 (89%) and mammography in 706 (89%) (P = not significant). Either US or mammogram was positive in 770 (97%). Of 537 (67%) symptomatic patients, US was positive in 497 (93%) and mammography in 465 (87%). Either US or mammography was positive in 515 (96%). Of 259 (33%) screening patients, 220 (85%) had invasive cancer. US was positive in 195 (89%) and mammography in 203 (92%) (P = not significant). Either US or mammography was positive in 217 (99%). Of 39 screening patients with ductal carcinoma in situ (5% of all patients), US was positive in 18 (46%) and mammography in 38 (97%). CONCLUSIONS: US is significantly better than mammography for detecting invasive breast cancer (92% patients). The combination of US and mammography is significantly better than either modality used alone, together resulting in 9% more breast cancers detected.
OBJECTIVE: This study investigated the use of ultrasound (US) as a first-line diagnostic tool. METHODS: All women attending our breast center underwent bilateral whole-breast US in addition to all other investigations, and results were documented prospectively and preoperatively. RESULTS: Of 796 patients with breast cancer, US was positive in 710 (89%) and mammography in 706 (89%) (P = not significant). Either US or mammogram was positive in 770 (97%). Of 537 (67%) symptomatic patients, US was positive in 497 (93%) and mammography in 465 (87%). Either US or mammography was positive in 515 (96%). Of 259 (33%) screening patients, 220 (85%) had invasive cancer. US was positive in 195 (89%) and mammography in 203 (92%) (P = not significant). Either US or mammography was positive in 217 (99%). Of 39 screening patients with ductal carcinoma in situ (5% of all patients), US was positive in 18 (46%) and mammography in 38 (97%). CONCLUSIONS: US is significantly better than mammography for detecting invasive breast cancer (92% patients). The combination of US and mammography is significantly better than either modality used alone, together resulting in 9% more breast cancers detected.
Authors: Laura Holzer-Fruehwald; Matthias Meissnitzer; Michael Weber; Stephan Holzer; Klaus Hergan; Christian Weismann Journal: Ultrasound Int Open Date: 2017-09-01
Authors: Hendrik J Teertstra; Claudette E Loo; Maurice A A J van den Bosch; Harm van Tinteren; Emiel J T Rutgers; Sara H Muller; Kenneth G A Gilhuijs Journal: Eur Radiol Date: 2009-08-06 Impact factor: 5.315
Authors: Berit Velstra; Yuri E M van der Burgt; Bart J Mertens; Wilma E Mesker; André M Deelder; Rob A E M Tollenaar Journal: J Cancer Res Clin Oncol Date: 2012-07-05 Impact factor: 4.553
Authors: Anouck Huijbers; Berit Velstra; Tim J A Dekker; Wilma E Mesker; Yuri E M van der Burgt; Bart J Mertens; André M Deelder; Rob A E M Tollenaar Journal: Int J Mol Sci Date: 2010-10-26 Impact factor: 5.923